Circulating tumor DNA for prognostication and monitoring in patients with metastatic endometrial carcinoma treated with olaparib: validation in the GINECO-UTOLA trial.
Beinse G, Taly V, Leary A, Baures A, Ray-Coquard I, You B, Rodrigues M, Gladieff L, Abadie-Lacourtoisie S, Bengrine-Lefevre L, Brachet PE, Lebreton C, Meynard G, Fournel P, Frenel JS, Selle F, Largillier R, Foa C, Cornila C, Kaczmarek E, Hardy-Bessard AC, D'Hondt V, Cojean Zelek I, Roche S, Duliege D, Mouret-Reynier MA, Bouchaert P, Laurent-Puig P, Joly F, Alexandre J.
Beinse G, et al. Among authors: taly v.
Clin Cancer Res. 2026 Jan 15. doi: 10.1158/1078-0432.CCR-25-2959. Online ahead of print.
Clin Cancer Res. 2026.
PMID: 41537701